Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)
19.18
-0.07 (-0.36%)
Feb 27, 2026, 3:00 PM CST
SHA:603079 Market Cap
SHA:603079 has a market cap or net worth of 3.59 billion as of February 27, 2026. Its market cap has increased by 59.29% in one year.
Market Cap
3.59B
Enterprise Value
3.34B
Revenue
839.82M
Ranking
n/a
PE Ratio
56.95
Stock Price
19.18
Market Cap Chart
Since August 23, 2017, SHA:603079's market cap has increased from 1.74B to 3.59B, an increase of 106.49%. That is a compound annual growth rate of 8.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.59B | 8.24% |
| Dec 31, 2025 | 3.32B | 45.41% |
| Dec 31, 2024 | 2.28B | -8.28% |
| Dec 29, 2023 | 2.49B | 15.73% |
| Dec 30, 2022 | 2.15B | -27.46% |
| Dec 31, 2021 | 2.96B | -19.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hunan Hansen Pharmaceutical | 3.80B |
| Harbin Medisan Pharmaceutical | 3.79B |
| Tibet AIM Pharm. | 3.77B |
| Nanjing Well Pharmaceutical Group | 3.75B |
| PKU HealthCare Corp.,Ltd. | 3.74B |
| Anhui Sunhere Pharmaceutical Excipients | 3.72B |
| Zhejiang Cheng Yi Pharmaceutical | 3.71B |
| Tuoxin Pharmaceutical Group | 3.67B |